Percuros is currently co-ordinating a European Union Marie Curie IAPP project, BRAINPATH, to build upon current developments in molecular imaging. The consortium will create an academic-industrial training and mobility network for the next revolution of imaging technology for the brain. The other partners in the consortium are Max Planck Institute for Neurological Research, Leiden University Medical Center, icoMetrix N.V., University of Antwerp, Technical University of Munich, FOM-AMOLF (Institute for Atomic and Molecular Physics and Medres GmbH.
Percuros was recently awarded, as co-ordinator, a European Commission MSCA-ITN-2015-ETN Action grant to investigate the use of nanoparticles for combination immunotherapy. This work will be performed in conjunction with a number of European partners both for academia and industry. Nineteen early stage researchers have been recruited across the partner sites where the project will start at the end of this year. For more infomation: www.ispic.eu
Percuros has been awarded three more grants and will launch three projects:
- PREPARED – A EUROSTARS funded project together with two organisations from Denmark, Atonomics and The Parker Institute (Copenhagen University Hospital), both based in Copenhagen. The program will allow the development of new point-of-care assays for therapeutic monitoring of rheumatoid arthritis.
- CANCER – A European H2020 MSCA RISE grant to study how the new cancer immunotherapy checkpoint blockers affect patients in terms of their quality of life and the impact of such treatment on their long term immune status.
- ARCATOR - A three-year project funded by EUROSTARS together with SIMFO GmbH, based in Bayreuth (Germany) to work on mid-throughput assays for measuring circulating tumour cells in liquid biopsies.